Nedocromil
Error creating thumbnail: File missing | |
Clinical data | |
---|---|
Routes of administration | Inhalation and eye drops |
ATC code | |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Protein binding | 89% |
Metabolism | not metabolized |
Elimination half-life | ~3.3 hours |
Excretion | excreted unchanged |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C19H17NO7 |
Molar mass | 371.341 g/mol |
WikiDoc Resources for Nedocromil |
Articles |
---|
Most recent articles on Nedocromil |
Media |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Nedocromil at Clinical Trials.gov Clinical Trials on Nedocromil at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Nedocromil
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Nedocromil Discussion groups on Nedocromil Patient Handouts on Nedocromil Directions to Hospitals Treating Nedocromil Risk calculators and risk factors for Nedocromil
|
Healthcare Provider Resources |
Causes & Risk Factors for Nedocromil |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Nedocromil sodium is a medication used to prevent wheezing, shortness of breath, and other breathing problems caused by asthma. It is administered by an inhaler under the brand name Tilade.
Nedocromil is classified as a cromone. Nedocromil acts as a mast cell stabilizer, inhibits the degranulation of mast cells, prevents release of histamine and tryptase, so preventing the synthesis of prostaglandins and leukotrienes.